Clinical Trials Directory

Trials / Completed

CompletedNCT03577587

Efficacy of Herbal Galactagogue Silitidil After Preterm Birth

Effect and Efficacy of the Herbal Galactagogue Silitidil From Milk Thistle in Mothers of Very Preterm Newborns

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
106 (actual)
Sponsor
Waldkrankenhaus Protestant Hospital, Spandau · Academic / Other
Sex
Female
Age
Healthy volunteers
Accepted

Summary

After preterm birth mothers often suffer from hypogalactia. Herbal galactogogues can be used in order to increase milk production. In this double-blind, randomized, placebo-controlled clinical trial the effect of Silitidil, an extract from milk thistle, on the postpartal milk production in mothers of very premature newborns is investigated.

Detailed description

Mothers of preterm infants born at a gestational age \<= 32 wg are asked to participate in this double-blind, randomized, placebo-controlled interventional trial, where they will receive a preparation of the herbal galactogogue Silitidil or placebo over an intervention period of 3 weeks. The influence of the galactagogue will be investigated by monitoring daily milk production before, during and 1 week after cessation of the intervention. As secondary outcome parameters weight gain, the progress of enteral feeding, and the percentage of human milk feeding on total enteral feeding volumes will be monitored in the newborn infants. Also the breast milk composition (in terms of fatty acids, protein and carbohydrates content) will be investigated and compared between study groups. Saliva and urine probes will be collected at specific time points to survey hormonal reactions during the various phases of lactation and the relation of maternal hormone levels on milk production.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTSilitidil for 21 daysdaily ingestion of herbal galactagogue Silitidil over time period of 3 weeks
DIETARY_SUPPLEMENTPlacebo for 21 daysdaily ingestion of Placebo preparation over time period of 3 weeks

Timeline

Start date
2017-08-14
Primary completion
2022-02-10
Completion
2022-02-10
First posted
2018-07-05
Last updated
2022-05-03

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT03577587. Inclusion in this directory is not an endorsement.